삼성서울병원

Ko En

Hematology-Oncology Lee, Jeeyun M.D

Expertise
Gastric cancer, colorectal cancer, sarcoma, melanoma, others
Treament Schedule 10 月
DATE
TUE
01
WEB
02
THU
03
FRI
04
SAT
05
SUN
06
MON
07
TUE
08
WEB
09
THU
10
FRI
11
SAT
12
SUN
13
MON
14
TUE
15
WEB
16
THU
17
FRI
18
SAT
19
SUN
20
MON
21
TUE
22
WEB
23
THU
24
FRI
25
SAT
26
SUN
27
MON
28
TUE
29
WEB
30
THU
31
AM
PM
Treament Schedule 11 月
DATE
FRI
01
SAT
02
SUN
03
MON
04
TUE
05
WEB
06
THU
07
FRI
08
SAT
09
SUN
10
MON
11
TUE
12
WEB
13
THU
14
FRI
15
SAT
16
SUN
17
MON
18
TUE
19
WEB
20
THU
21
FRI
22
SAT
23
SUN
24
MON
25
TUE
26
WEB
27
THU
28
FRI
29
SAT
30
AM
PM

Medical Education

2005 Ph.D. in Medicine Graduate School of Sungkyunkwan University, Korea
2002 Master of Science Graduate School of Sungkyunkwan University, Korea
1999 College of Medicine, Ewha Womans University, Korea

Post-Graduate Training

Fellowship   2004~2005 Clinical Fellowship in Hematology-Oncology, Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
Residency   2000~2003 Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
Internship   1999~2000 Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

Professional Appointments

2022~present Director Precision Oncology Center, Samsung Medical Center
2019~present Director Experimental Therapeutics Development Center, Samsung Medical Center
2019~2022 Member Member of Samsung Future Technology Meeting Committee, Korea
2020~present Professor Department of Intelligence Precision Convergence Engineering, SKKU, Suwon
2020~ Professor Division of Hem/Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine
2014~2020 Associate Professor Division of Hem/Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine
2010~2014 Assistant Professor Division of Hem/Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine
2006~2010 Clinical Assistant Professor Division of Hem/Oncology, Samsung Medical Center
2006~2008 Visiting Scientist Sidney Kimmel Cancer Center, San Diego, CA, USA
2005.07 completed AACR Workshop in Cancer Research: Molecular Biology in Clinical Oncology
2004.08 completed Australia and Asia Pacific Clinical Oncology Research Development Workshop: A Workshop in Effective Clinical Trials Design

Professional Memberships

Present Member American Society of Clinical Oncology
Present Member AACR
Present Member Korean Association of Clinical Oncology

Selected Publications

  • EUR RADIOL 2021 10.1007/s00330-021-08094-3 Prediction of epithelial-to-mesenchymal transition molecular subtype using CT in gastric cancer Cha1, DI; Lee, J; Jeong, WK; Kim, ST; Kim, JH; Hong, JY; Kang, WK; Kim, KM; Kim, SW; Choi, D
    View PubMed
  • NATURE 2021 10.1038/s41586-021-03515-1 ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma Yen1, I; Shanahan, F; Lee, J; Hong, YS; Shin, SJ; Moore, AR; Sudhamsu, J; Chang, MT; Bae, I; Dela Cruz, D; Hunsaker, T; Klijn, C; Liau, NPD; Lin, E; Martin, SE; Modrusan, Z; Piskol, R; Segal, E; Venkatanarayan, A; Ye, X; Yin, JP; Zhang, LX; Kim, JS; Lim, HS; Kim, KP; Kim, YJ; Han, HS; Lee, SJ; Kim, ST; Jung, M; Hong, YH; Noh, YS; Choi, M; Han, O; Nowicka, M; Srinivasan, S; Yan, YB; Kim, TW; Malek, S
    View PubMed
  • CANCERS 2021 10.3390/cancers13102316 Validation of the Combined Biomarker for Prediction of Response to Checkpoint Inhibitor in Patients with Advanced Cancer Kim1, JC; Heo, YJ; Kang, SY; Lee, J; Kim, KM
    View PubMed
  • JAMA ONCOL 2021 10.1001/jamaoncol.2021.0275 Assessment of Pembrolizumab Therapy for the Treatment of Microsatellite Instability-High Gastric or Gastroesophageal Junction Cancer Among Patients in the KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 Clinical Trials Chao1, JS; Fuchs, CS; Shitara, K; Tabernero, J; Muro, K; Van Cutsem, E; Bang, YJ; De Vita, F; Landers, G; Yen, CJ; Chau, I; Elme, A; Lee, J; Ozguroglu, M; Catenacci, D; Yoon, HH; Chen, ER; Adelberg, D; Shih, CS; Shah, SK; Bhagia, P; Wainberg, ZA
    View PubMed
  • J DERMATOL 2021 10.1111/1346-8138.15824 Clinical profile of cutaneous adverse events of immune checkpoint inhibitors in a single tertiary center Park1, JH; Yoon, D; Lee, J; Oh, SJ; Kim, HJ; Lee, JH; Lee, DY
    View PubMed